This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ark Therapeutics Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Anu-Maaria Sandmair in Gene Therapy
Introduction
Anu-Maaria Sandmair is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of gene therapy through his innovative work, notably in the treatment of brain tumors.
Latest Patents
Anu-Maaria Sandmair holds one patent for his invention titled "Adenovirus-mediated gene therapy." This patent involves an adenovirus that possesses a functional thymidine kinase gene, which is deemed useful in the therapeutic approach to combat brain tumors.
Career Highlights
Sandmair has been associated with Ark Therapeutics Limited, a company known for its advancements in gene therapy and medical innovations. His work has played a crucial role in shaping novel treatment options for challenging medical conditions, particularly in oncology.
Collaborations
During his career, Anu-Maaria Sandmair has collaborated with esteemed colleagues such as Seppo Yla-Herttuala and Sami Loimas. Their joint efforts in research have contributed to heightened advancements in gene therapy techniques and applications.
Conclusion
Anu-Maaria Sandmair stands out as an influential inventor in the realm of gene therapy. His groundbreaking patent in adenovirus-mediated gene therapy highlights his commitment to improving treatment modalities for patients with brain tumors, showcasing the power of innovative thinking in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile